MYX Share Price Performance
AU$5.00
1.17 (30.55%)
Price AU$5.00
Share PriceAU$5.00
MYX Community Narratives
There are no narratives available yet.
Recent MYX News & Updates
No updates
Mayne Pharma Group Limited Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
Aug 29, 2025
- Earnings per share (EPS)
- -1.45
- Gross Margin
- 58.97%
- Net Profit Margin
- -28.54%
- Debt/Equity Ratio
- 7.5%
Mayne Pharma Group Limited Competitors
About MYX
- Founded
- 2005
- Employees
- n/a
- CEO
- WebsiteView website
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through three segments: Women’s Health, Dermatology, and International. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women’s health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Australian Market Performance
- 7 Days: -0.4%
- 3 Months: 6.8%
- 1 Year: 13.2%
- Year to Date: 5.2%
Over the last 7 days, the market has remained flat, although notably the Materials sector declined by 4.2%. As for the longer term, the market has risen 8.6% in the past 12 months. Earnings are forecast to grow by 11% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading